Evolution of the Average Target: Alcon Inc.

Evolution of the Target Price: Alcon Inc.

Changes in Analyst Recommendations: Alcon Inc.

b9c02c.hdKP41SWwWsEr0iD5NVcBTg-15ff0gT3HZeKK1lEcgo.0Oq4mmXElQh0zh-2o-1oUlxo7vPylnWgMNzEBit1Qk_HluCZFsDxND3kfA~340d38b9f64677e1582567e14a471ecd
08-17 Deutsche Bank raises TP for Alcon, but shares down Zonebourse
08-13 BNP Paribas Downgrades Alcon to Neutral, Cuts PT MT
08-13 Bernstein Updates Alcon Estimates, Price Target After 'Strong' Commercial Execution in Q2 MT
08-11 Alcon: Q2 story: Innovation is being well received by the end market Alphavalue
05-25 Baptista Research Upgrades Alcon to Buy Rating MT
05-12 Swiss Market Index Closes Higher; SoftwareOne Shares Jump MT
05-08 Bernstein Keeps Alcon at Outperform After Q1 Results; Estimates, Price Target Revised MT
05-07 Needham Trims Price Target on Alcon to $95 From $100, Keeps Buy Rating MT
05-06 Alcon: Results weren't bad; today's correction is a buying opportunity Alphavalue
05-06 Alcon Price Target Declines as AlphaValue/Baader Cuts Estimates on Rising Competition, Expenses MT
05-06 Swiss stocks - Factors to watch on May 6 RE
05-05 Alcon: Investment case hinges on profitability expansion Alphavalue
04-21 RBC Bullish on Alcon's FY26 Growth Outlook; Outperform Maintained MT
03-19 AlphaValue/Baader Europe Upgrades Alcon to Add Rating, Lifts PT MT
03-16 Bernstein: Risk in Alcon's Implantables Business 'Manageable,' Already Priced In MT
03-10 Bernstein Says Alcon Top Pick in European Medtech Coverage, Notes 'Good Momentum' for Key Products into FY26 MT
03-06 Berenberg Keeps Alcon at Buy Amid Signs of US Cataract Market Rebound MT
03-04 Alcon Kept at Outperform as RBC Notes 'Positive Setup' Through FY26; Estimates Revised MT
02-27 Equita SIM Upgrades Alcon to Buy, Raises PT MT
02-26 Needham Raises Price Target on Alcon to $100 From $98, Keeps Buy Rating MT
02-26 Wells Fargo Upgrades Alcon AG to Overweight From Equal Weight, Adjusts PT to $97 From $88 MT
02-26 Alcon Estimates Tweaked as Bernstein Notes Potential Upside from End-market Recovery; Price Target Up MT
02-25 Alcon: Markets forgive Q4 miss for a healthy 2026 outlook Alphavalue
02-18 RBC Updates Alcon Estimates Ahead of FY25 Earnings; Outperform Rating Kept MT
02-11 RBC Expects Alcon's Upcoming FY26 Guidance to Drive Share Price Volatility; Outperform Rating Kept MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+52.26%
+25.73%
+8.52%
+8.93%
+58.14%
+22.97%
+14.97%
+62.44%
+10.2%
Average +29.35%
Weighted average by Cap. +38.21%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
74.25USD
Average target price
91.40USD
Spread / Average Target
+23.10%
High Price Target
105.05USD
Spread / Highest target
+41.47%
Low Price Target
59.24USD
Spread / Lowest Target
-20.21%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BNP Paribas
alphavalue Abhishek Raval
Baptista Research
Needham & Co.
AlphaValue/Baader Europe
Equita SIM
Wells Fargo Securities
Deutsche Bank Securities
Citigroup
Barclays
Kepler Cheuvreux
Deutsche Bank Research
Redburn Atlantic
Ameriprise Advisor Services
RBC Capital Markets
Berenberg Bank
UBS
Oppenheimer
Stifel Nicolaus
Baird
Argus
Mizuho Securities
KeyBanc Capital Markets
Bernstein
Morgan Stanley
Jefferies & Co.
BNP Paribas Exane
Nephron Research
Societe Generale
JPMorgan Chase
BTIG
Credit Suisse
DA Davidson
Stephens Inc.
Goldman Sachs
Exane BNP
Kepler Capital Markets
SVB Leerink
Davy
Octagon Capital
JPMORGAN James Gordon
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
74.25USD
Average target price
91.40USD
Spread / Average Target
+23.10%

Quarterly revenue - Rate of surprise